CCL18 and EGF May Serve as Potential Prognostic Biomarkers and Therapeutic Targets for Human Breast Cancer.

Int J Breast Cancer · 2025 · PMC12279427 · PMID 40692603

Europe PMC DOI

hedged sentence

0.1800

closest p · 3.6× alpha

0.1800

boldest claim

The sentences

did not reach statistical significancep = 0.18not close (p > 0.1)

However, across the entire BRCA cohort, the survival differences between high and low/medium expression groups for both genes did not reach statistical significance (CCL18, p = 0.18; EGF, p = 0.16) ( Figure 4c,d ), highlighting the potential influence of menopausal status and hormonal milieu on gene-related prognosis.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.